BG
LCTX icon

BlackRock Group’s Lineage Cell Therapeutics LCTX Stock Holding History

BlackRock Group’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$179K Buy
56,974
+14,020
+33% +$43K ﹤0.01% 2692
2016
Q3 		$146K Hold
42,954
– – ﹤0.01% 2728
2016
Q2 		$98K Hold
42,954
– – ﹤0.01% 2797
2016
Q1 		$108K Buy
42,954
+36,270
+543% +$80.9K ﹤0.01% 2742
2015
Q4 		$22K Hold
6,684
– – ﹤0.01% 2929
2015
Q3 		$16K Buy
+6,684
New +$17.3K ﹤0.01% 3000

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $305M AUM 95.53% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return